Has Tim Fischell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $492,334 in general payments to Tim Fischell, MD across 320 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tim Fischell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tim Fischell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tim Fischell, MD

Interventional Cardiology · Kalamazoo, MINPI 1891771440

Payments from drug & device makers

$492,334in general payments, 2019–2025

Across 320 payments — averaging $1538.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bard Peripheral Vascular, Inc.$248K
Cordis Corporation$88K
Medtronic$52K
Cordis US CORP.$42K
Avertix Medical, Inc$24K
Medalliance LLC$15K
plus $23K from 42 others

What the payments were for

Royalty or licence$208,21644%
Food & beverage$10,8222%
Gifts$750%
Ownership interest$8360%
Other$248,12353%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bard Peripheral Vascular, Inc.	2	$248,123
Cordis Corporation	13	$88,212
Medtronic(2 entities)	13	$51,924
Cordis US CORP.	15	$42,048
Avertix Medical, Inc	2	$24,210
Medalliance LLC	4	$14,965
Abbott	59	$7,049
M.a. Med Alliance S.A.	1	$4,395
Merit Medical Systems Inc	16	$3,785
Boston Scientific	31	$1,085
Shockwave Medical, Inc	26	$1,065
Penumbra, Inc.	8	$680
Abiomed	11	$595
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	14	$454
Stryker	3	$366
Inari Medical, Inc.	4	$343
Chiesi USA, Inc.	9	$308
Novartis	17	$301
Heartflow, Inc.	4	$281
E.r. Squibb & Sons, L.L.C.	6	$190
Kestra Medical Technology Services, Inc.	4	$167
Angiodynamics, Inc.	2	$158
Amgen	4	$157
Recor Medical Inc	3	$147
Johnson & Johnson	4	$147
Opsens Inc.	1	$145
Cardinal Health 200 LLC	3	$142
AstraZeneca	7	$134
Terumo Medical Corporation	1	$125
Philips North America LLC	2	$119
Edwards Lifesciences	2	$106
Actelion Pharmaceuticals US, Inc.	3	$61
Nipro Medical Corporation	1	$61
Teleflex LLC	3	$51
ZOLL Circulation Inc	2	$38
Cardiva Medical, Inc.	1	$33
Imperative Care, Inc	1	$31
Novo Nordisk	1	$28
Biosense Webster, Inc.	1	$25
W. L. Gore & Associates, Inc.	1	$21
Kiniksa Pharmaceuticals International, PLC	1	$19
Boehringer Ingelheim	1	$17
Acist Medical Systems, Inc.	1	$14
Cardiovascular Systems Inc.	1	$9
Ablative Solutions, Inc.	4	$0
Cardio Flow, Inc.	1	$0
Vantis Vascular, Inc.	2	$0
Neuropace, Inc.	4	$0

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VenaSeal$51,395
Ostial Pro Stent Position Sys$2,581
Ostial Pro Stent Position System$1,129
Indigo System$376
FLOWTRIEVER CATHETER, S$372
CT THROMBECTOMY SYSTEM KIT$372
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$297
Impella$238
Perclose ProGlide suture mediated closure system$165
CardioMEMS HF System$153
OPTIS$148
OptoWire$145
ABSOLUTE PRO$140
SYMPLICITY G3$137
Indigo$135
FlowTriever$128
MYNX CONTROL$125
Navicross$125
AngioVac$123
Optis Coronary Imaging System$123

How this compares

$492,334 in reported general payments places this provider in the 90th percentile of 187 interventional cardiology providers in Michigan.

See all interventional cardiology providers in Michigan →

Medicare billing

Part B allowed, 2024

$16,676

Medicare patients

Services billed

138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	31	$30,292
EliquisApixaban	25	$23,397
Ranolazine ErRanolazine	53	$4,511
Prasugrel Hcl	25	$1,785
Nitroglycerin	34	$1,404
Atorvastatin Calcium	77	$1,250
Metoprolol Succinate	62	$764
ClopidogrelClopidogrel Bisulfate	42	$500
Amlodipine Besylate	66	$479
Rosuvastatin Calcium	21	$360
Ezetimibe	12	$305
Metoprolol Tartrate	32	$255
Carvedilol	15	$198
Lisinopril	26	$191
Losartan Potassium	13	$175

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Kalamazoo

Vishal GuptaKalamazoo$510K
Frank SaltielKalamazoo$60K
Amir KakiDetroit$2.3M
William MerhiGrand Rapids$2M
Shukri DavidSouthfield$1.6M
Qaiser ShafiqSouthgate$1.3M
Marcel ZughaibSouthfield$1.2M
Jason RicciPetoskey$1.1M
Khaldoon AlaswadDetroit$1.1M
Paul GrossmanAnn Arbor$1.1M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →